Citigroup Inc Ampio Pharmaceuticals, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.08 - $21.0 $3,229 - $847,854	-40,374 Reduced 98.34%	680 $0
Q2 2022 Aug 10, 2022	BUY	$0.16 - $0.47 $4,357 - $12,799	27,234 Added 197.06%	41,054 $7,000
Q1 2022 May 12, 2022	SELL	$0.42 - $0.62 $15,570 - $22,985	-37,073 Reduced 72.84%	13,820 $6,000
Q4 2021 Feb 10, 2022	BUY	$0.56 - $1.71 $15,055 - $45,971	26,884 Added 111.97%	50,893 $29,000
Q3 2021 Nov 10, 2021	BUY	$1.21 - $1.8 $29,050 - $43,216	24,009 New	24,009 $40,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.